It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
It turns out that Obama has had lobbyists from Big Pharma in contact with the White House negotiating on their behalf about the "comprehensive" health care reform measures. The White House has signaled that it won't support two things we need in order to fix the problem in return for the Drug Lobby's support on the rest of the package.
He's a millionaire and President, why would it matter to him if he made Pharmacutical companies rich?
you'd think that extra 30$ a month outta your taxes will make
not 1,000 page Bills!
Prescription drug manufacturers, represented by their trade and lobbying group, Pharmaceutical Research and Manufacturers of America (PhRMA), have one of the most powerful and successful lobbies in Congress.
In fact, the Congressional Budget Office projects that if drug manufacturers were required to give Medicare Part D plans the same rebates they give the Medicaid program, the federal government would save $110 billion over ten years—$30 billion more than PhRMA’s offer with that single change.
Language was inserted into the law that explicitly prohibited the government from directly negotiating with drug manufacturers for lower drug prices. That has meant billions of dollars in extra profits and an assurance that the government would not interfere in how they set their prices.
Their gain was our loss. As I explained in a previous post, evidence shows that the prices negotiated by the private Medicare Part D plans are substantially higher than prices that government-run programs like the Department of Veterans Affairs (VA), Medicare Part B, Medicaid and those in other countries are able to obtain for their patients. The private plans' inability to secure better prices has meant higher costs for people with Medicare and for taxpayers.